ES2063432T3 - Compuestos farmaceuticos orales de dosis unitaria. - Google Patents

Compuestos farmaceuticos orales de dosis unitaria.

Info

Publication number
ES2063432T3
ES2063432T3 ES91200029T ES91200029T ES2063432T3 ES 2063432 T3 ES2063432 T3 ES 2063432T3 ES 91200029 T ES91200029 T ES 91200029T ES 91200029 T ES91200029 T ES 91200029T ES 2063432 T3 ES2063432 T3 ES 2063432T3
Authority
ES
Spain
Prior art keywords
oral pharmaceutical
unit dose
pharmaceutical compounds
cbs
auxilliary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91200029T
Other languages
English (en)
Spanish (es)
Inventor
Jan Willem Groenendaal
Aart Muhlenbruch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BROCADES PHARMA BV
Original Assignee
BROCADES PHARMA BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BROCADES PHARMA BV filed Critical BROCADES PHARMA BV
Application granted granted Critical
Publication of ES2063432T3 publication Critical patent/ES2063432T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES91200029T 1990-01-09 1991-01-09 Compuestos farmaceuticos orales de dosis unitaria. Expired - Lifetime ES2063432T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90200064 1990-01-09

Publications (1)

Publication Number Publication Date
ES2063432T3 true ES2063432T3 (es) 1995-01-01

Family

ID=8204917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91200029T Expired - Lifetime ES2063432T3 (es) 1990-01-09 1991-01-09 Compuestos farmaceuticos orales de dosis unitaria.

Country Status (18)

Country Link
US (1) US5264222A (fi)
EP (1) EP0437294B1 (fi)
KR (1) KR910014124A (fi)
AT (1) ATE101039T1 (fi)
AU (1) AU638083B2 (fi)
CA (1) CA2033870A1 (fi)
DE (1) DE69101111T2 (fi)
DK (1) DK0437294T3 (fi)
ES (1) ES2063432T3 (fi)
FI (1) FI910088A (fi)
HU (1) HU204707B (fi)
IE (1) IE910057A1 (fi)
IL (1) IL96904A0 (fi)
MY (1) MY106371A (fi)
NO (1) NO910080L (fi)
NZ (1) NZ236721A (fi)
PT (1) PT96437A (fi)
ZA (1) ZA91178B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) * 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
AU4596796A (en) * 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with bismuth and antibacterials
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
WO1997007757A1 (en) * 1995-08-24 1997-03-06 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms
EP0941102A1 (en) * 1996-11-22 1999-09-15 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid
WO1998022117A1 (en) * 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
DE19913606A1 (de) * 1999-03-25 2000-09-28 Basf Ag Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
WO2021072350A1 (en) * 2019-10-11 2021-04-15 Tobebio Novel Drug Co., Ltd. Synergistic combination of chemotherapy and peptide for treating cancer
CN111214443A (zh) * 2020-02-23 2020-06-02 北京鑫开元医药科技有限公司 一种枸橼酸铋钾颗粒及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4670245A (en) * 1984-04-27 1987-06-02 Vasquez Tony E Diagnostic procedures using radiolabeled colloidal bismuth subcitrate and related compounds
CA1207239A (en) * 1984-08-10 1986-07-08 Upendra K. Banik Gastrointestinal compositions
SG72632A1 (en) * 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
DE3650504T2 (de) * 1985-06-13 1996-10-31 Marshall Barry James Verfahren und Zusammensetzungen zur Behandlung von gastrointestinalen Störungen
GB8612401D0 (en) * 1986-05-21 1986-06-25 Evode Ltd Liquid polmers
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
AU623868B2 (en) * 1987-10-12 1992-05-28 Capability Services Pty. Limited Improved method for treatment of gastrointestinal disorders
EP0375068A1 (en) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Combining bismuth compounds and tetracyclines

Also Published As

Publication number Publication date
FI910088A (fi) 1991-07-10
MY106371A (en) 1995-05-30
PT96437A (pt) 1991-10-15
ZA91178B (en) 1991-10-30
AU6869391A (en) 1991-07-11
NO910080D0 (no) 1991-01-08
CA2033870A1 (en) 1991-07-10
US5264222A (en) 1993-11-23
DE69101111D1 (de) 1994-03-17
DK0437294T3 (da) 1994-03-07
KR910014124A (ko) 1991-08-31
NO910080L (no) 1991-07-10
FI910088A0 (fi) 1991-01-07
NZ236721A (en) 1992-08-26
IE910057A1 (en) 1991-07-17
EP0437294A1 (en) 1991-07-17
DE69101111T2 (de) 1994-07-28
AU638083B2 (en) 1993-06-17
EP0437294B1 (en) 1994-02-02
IL96904A0 (en) 1992-03-29
ATE101039T1 (de) 1994-02-15
HU204707B (en) 1992-02-28

Similar Documents

Publication Publication Date Title
ES2063432T3 (es) Compuestos farmaceuticos orales de dosis unitaria.
IE862554L (en) Pharmaceutical compositions
BR1100776A (pt) Forma de dosagem farmacêutica comprimida e obréia farmacêutica comprimida.
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
EP0552256A4 (fi)
IT8320212A0 (it) Capsula osmotica per l'erogazione di due sostanze medicinali differenti.
PT100973A (pt) Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
FR2682040B1 (fr) Medicaments pour traiter les troubles gastrointestinaux.
AU8188691A (en) The use of inositoltrisphosphate for the preparing of medicaments
IL103516A0 (en) Cytotoxic bicyclo(7,3,1)tridec-4-ene-2,6-diyne compounds,process for the preparation thereof and pharmaceutical compositions containing them
DE69006654D1 (de) Einen Zink-Komplex enthaltende Arzneimittel.
ES2024010B3 (es) Unidad de dosis farmaceutica.
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
FR2675802B1 (fr) Antiserotonines, leur preparation et les medicaments les contenant.
DE3263832D1 (en) Gallium chloride, an anti-cancer drug
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
DE68909555D1 (de) Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung.
GB2052980B (en) Pharmaceutical composition for oral administration comprising methoxsalen
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
DE3064854D1 (en) Quail-egg lyophilisate for the treatment of immuno-allergic diseases
DE3484155D1 (de) Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216.
DE3676097D1 (de) 15(r)-5-fluorprostazykline und diese verbindungen enthaltende arzneimittel.
ES2101982T3 (es) Composicion conteniendo una alta dosis de vitamina a.
IT8421627A1 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo
ATE50995T1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.